• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/30

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

30 Cards in this Set

  • Front
  • Back
CLL is ___. SLL is ___. MBL is ___
chronic lymphocytic leukemia
small lymphocytic leukemia
monoclonal B cell lymphocytosis
5 markers for monoclonal B lymphocytosis
CD5
CD19
CD23
SmIg weak
CD20 weak
if B cell count with markers is >___, it's ___.
5000/uL
CLL
3 criteria for SLL
<5000 cells/uL
enlarged liver/spleen
enlarged LNs
if any of the SLL criteria fail to obtain, dx is ___
MBL
___% of CLL pts are asymptomatic at dx
40
when symptomatic CLL presents with ___
fatigue
CLL lymphocytes are mature/immature
mature
level of ___ in CLL correlates with severity of disease
beta2 microglobulin
___ cells are classic marker for CLL
smudge
___ is done to confirm dx of CLL
immunophenotyping
CLL cells may express ___ on membrane
Ig light chain
___gammaglobulinemia is characteristic of CLL
hypo
10-25% of CLL pts develop ___ or ___
AIHA
ITP
in CLL >___% of nucleated cells in BM aspirate are lymphoid
30
2 genes implicated in CLL
p53
ATM
p53 is on chromosome ___
ATM is on chromosome ___
17p
11q
in CLL, ATM mutations are associated with ___
lymphadenopathy
in CLL, p53 mutations are associated with ___
resistance to tx
another bad cytogenetic marker in CLL is ___
unmutated V_H
2 markers that correlate with V_H mutation status
ZAP-70
CD38
ZAP-70 is a ___ expressed in B CLL cells
Y kinase
in addition to cytogenetic markers, ___ (3) are prognostic factors
age
lymphocyte count
LDH
2 alkylating agents for CLL
chlorambucil
CTX
2 nucleoside analogs for CLL
cladribine
fludarabine
standard tx for CLL
fludarabine
CTX
rituximab
pts with p53 mutation receive ___ aka ___
anti-CD52
alemtuzumab
only cure for CLL is ___
allogeneic SC transplant
in Richter's syndrome, CLL transforms to ___, e.g.
aggressive lymphoma
DLBCL
T/F: CLL predisposes to second primary ca
true